CAR-T Immunotherapy

Revolutionary therapy for relapsed/refractory B-cell lymphoma and multiple myeloma.

Reference cost:

¥800,000 - ¥1,200,000

Treatment period:

4-6 weeks

Recovery time

4-8 weeks

Success rate:

70-85%

CAR-T immunotherapy is a revolutionary treatment for relapsed/refractory B-cell lymphoma and multiple myeloma.

Cost reference: ¥800,000 - ¥1,200,000 (excluding flights and accommodation)

Treatment duration in China: 4-6 weeks; post-operative recovery: 4-8 weeks.

Available Destinations

Contact our medical advisors